-Toshihiko Kato Researcher Activity Profile

Research Author Detailed Information 

Toshihiko Kato Publication Rate By Year

Toshihiko Kato has published 7 paper(s) in 2007, for a total of 7 research publications in total.

Toshihiko T Kato Author Information

LAST NAME: kato

FIRST NAME: toshihiko

INITIALS: T

AFFILIATION:

Papers

Toshihiko Kato's Publication Record

1. Unique peptide:N-glycanase of Caenorhabditis elegans has activity of protein disulphide reductase as well as of deglycosylation. Year Published: 2007
Division of Integrated Life Science, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan.
2. Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test. Year Published: 2007
Department of Internal Medicine, Chuno Kosei Hospital, Gifu, Japan.
3. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma: successful treatment with interferon-alpha. Year Published: 2007
Department of Dermatology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan. tmitsu@nms.ac.jp.
4. Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test. Year Published: 2007
Department of Internal Medicine, Chuno Kosei Hospital, Gifu, Japan.
5. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma: successful treatment with interferon-alpha. Year Published: 2007
Department of Dermatology, Nippon Medical School, Tokyo, Japan.
6. Unique peptide:N-glycanase of Caenorhabditis elegans has activity of protein disulphide reductase as well as of deglycosylation. Year Published: 2007
Division of Integrated Life Science, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan.
7. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma: successful treatment with interferon-alpha. Year Published: 2007
Department of Dermatology, Nippon Medical School, Tokyo, Japan.